Wachovia downgrades Fresenius Medical (NYSE: FMS) from Outperform to Market Perform with a $55 to $58 valuation range.

This article: 125 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE